Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 3 Hepatitis C Virus”

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT01797848
What this trial is testing

Efficacy and Safety Evaluation of a Treatment Consisting of Peg Interferon Alfa + Ribavirin + Daclatasvir in HCV Genotype 1 and 4 Treatment naïve Patients

Who this might be right for
Hepatitis C
Bristol-Myers Squibb
Post-approval studies (Phase 4)Ended earlyNCT00803309
What this trial is testing

Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients

Who this might be right for
Hepatitis C, Chronic
HepNet Study House, German Liverfoundation 99
Large-scale testing (Phase 3)WithdrawnNCT01517308
What this trial is testing

24 VS 48-WEEK TREATMENT WITH PEG-IFN ALPHA-2A IN PATIENTS WITH GENOTYPE 2/3 CHRONIC HEPATITIS C

Who this might be right for
Chronic Hepatitis C
Federico II University
Large-scale testing (Phase 3)UnknownNCT04001608
What this trial is testing

Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 1 Hepatitis C Virus Infection Patients

Who this might be right for
Hepatitis C Virus Infection
Ginkgopharma CO., LTD 206
Large-scale testing (Phase 3)Study completedNCT02939989
What this trial is testing

Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study

Who this might be right for
Hepatitis C Virus Infection
AbbVie 33
Testing effectiveness (Phase 2)Study completedNCT01260350
What this trial is testing

Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3

Who this might be right for
Chronic Hepatitis C Infection
Gilead Sciences 292
Testing effectiveness (Phase 2)Study completedNCT02601573
What this trial is testing

Elbasvir/Grazoprevir (EBR/GZR) and Sofosbuvir (SOF) With and Without Ribavirin (RBV) in Cirrhotic Subjects With Chronic Hepatitis C Virus (HCV) Genotype 3 (GT3) Infection (MK-5172-083)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 101
Large-scale testing (Phase 3)Study completedNCT03362814
What this trial is testing

Efficacy and Safety of Ravidasvir in Combination With Danoprevir/r and Ribavirin(RBV) in Treatment-naive, Non-cirrhotic, Chronic Hepatitis C Virus Genotype1 Infected Subjects.

Who this might be right for
HCV
Ascletis Pharmaceuticals Co., Ltd. 425
Large-scale testing (Phase 3)Study completedNCT00483938
What this trial is testing

The Individualized Management With Pegylated-interferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Offering Viral Eradication: A Study of Pegylated-interferon Alfa-2a Plus Ribavirin in Participants With Chronic Hepatitis C (CHC) Non-genotype 2/3 (IMPROVE)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 236
Large-scale testing (Phase 3)Study completedNCT02220998
What this trial is testing

Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 12 Weeks in Adults With Chronic Genotype 2 HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 269
Large-scale testing (Phase 3)Study completedNCT00627926
What this trial is testing

Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 1,095
Testing effectiveness (Phase 2)Ended earlyNCT01701063
What this trial is testing

An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 42
Testing effectiveness (Phase 2)Study completedNCT02569710
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Efficacy of the Combination of AL-335, Odalasvir, and Simeprevir

Who this might be right for
Chronic Hepatitis C
Alios Biopharma Inc. 161
Testing effectiveness (Phase 2)Study completedNCT02175758
What this trial is testing

Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children With Genotype 2 or 3 Chronic HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 106
Large-scale testing (Phase 3)Study completedNCT01945294
What this trial is testing

Short Duration Versus Standard Response-Guided Therapy With Boceprevir Combined With PegIntron and Ribavirin in Previously Untreated Non-Cirrhotic Asian Participants With Chronic HCV Genotype 1 (MK-3034-107)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 257
Large-scale testing (Phase 3)Study completedNCT01838590
What this trial is testing

Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus
Gilead Sciences 103
Large-scale testing (Phase 3)Study completedNCT01995266
What this trial is testing

Phase III China GT 1b Interferon (IFN) Intolerant Prev Exclude Dual

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 218
Large-scale testing (Phase 3)Study completedNCT01121705
What this trial is testing

Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3)

Who this might be right for
Chronic Hepatitis
Casa Sollievo della Sofferenza IRCCS 360
Not applicableStudy completedNCT01970904
What this trial is testing

Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients

Who this might be right for
Hepatitis CLiver Disease
Debiopharm International SA 147
Large-scale testing (Phase 3)Study completedNCT01468584
What this trial is testing

Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Non-responder Genotype 2 Hepatitis C Infected Patients

Who this might be right for
Chronic Hepatitis C
Tanabe Pharma Corporation 10
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation